FRASER CRAIG (President and CEO) purchased 2.1% of their position (4.50K shares) of WINDTREE THERAPEUTICS INC /DE/ on the open market
Open‑market purchase worth $1.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/5/2022ACC: 0001437749-22-016607
DirectorOfficer· President and CEO
Since Nov 2018
+4.50K
Net shares
Net buyer
$1.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.50K
Price / share
$0.43
Trade value
$1.93K
% of position
2.1%
6/30/2022
217.06K→221.56K
Total
Net shares
+4.50K
Net value
$1.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2022 | P · Purchase | +4.50K | $0.43 | $1.93K | 2.1% | 217.06K | 221.56K |
| Total | +4.50K | $1.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned147.00
Total
147.00 indirect147.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 147.00 | Indirect |
| Total | 147.00 | 147.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported